Among patients with hypertension, is the use of RAAS antagonists associated with severe COVID disease or COVID-related deaths? -

Among patients with hypertension, is the use of RAAS antagonists associated with severe COVID disease or COVID-related deaths?

Emerging Infections

Among patients with hypertension, is the use of RAAS antagonists associated with severe COVID disease or COVID-related deaths?

April 15, 2020May 18, 2020
by psmid_user

For any questions or information, please email: covidrapidreviewteam@gmail.com.

RAS antagonists abridged 1MAY2020 V 2.0

>> Return to Rapid Reviews list.

Should Leronlimab (PRO 140) be used in the treatment of COVID-19?

What is the second sedative agent to add to dexmedetomidine for sedation of COVID-19 patients?

psmid_user